
Sign up to save your podcasts
Or
Ninja Nerds,
Welcome to the Ninja Nerd Podcast with Zach and Rob! In this episode, we discuss Lung Cancer, a leading cause of cancer-related mortality worldwide. We explore the pathophysiology, risk factors, and key differences between non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) to help you master this complex topic.
Our discussion covers the clinical presentation of lung cancer, including subtle early symptoms like cough, hemoptysis, and chest pain, as well as advanced findings such as pleural effusions, superior vena cava syndrome, and paraneoplastic syndromes.
Finally, we break down treatment strategies based on staging and tumor type, covering surgical interventions, chemotherapy regimens, immunotherapy, and targeted therapies such as EGFR and ALK inhibitors. We also review the latest advancements in precision medicine and the evolving role of molecular markers in guiding therapy.
Whether you’re preparing for exams or rotations or seeking a deeper understanding of lung cancer, this episode is packed with high-yield insights to boost your clinical knowledge and critical thinking.
Enjoy the episode and support us below! 🌬️🫁
Listen on: Apple Podcasts Spotify
Support the show
4.9
282282 ratings
Ninja Nerds,
Welcome to the Ninja Nerd Podcast with Zach and Rob! In this episode, we discuss Lung Cancer, a leading cause of cancer-related mortality worldwide. We explore the pathophysiology, risk factors, and key differences between non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) to help you master this complex topic.
Our discussion covers the clinical presentation of lung cancer, including subtle early symptoms like cough, hemoptysis, and chest pain, as well as advanced findings such as pleural effusions, superior vena cava syndrome, and paraneoplastic syndromes.
Finally, we break down treatment strategies based on staging and tumor type, covering surgical interventions, chemotherapy regimens, immunotherapy, and targeted therapies such as EGFR and ALK inhibitors. We also review the latest advancements in precision medicine and the evolving role of molecular markers in guiding therapy.
Whether you’re preparing for exams or rotations or seeking a deeper understanding of lung cancer, this episode is packed with high-yield insights to boost your clinical knowledge and critical thinking.
Enjoy the episode and support us below! 🌬️🫁
Listen on: Apple Podcasts Spotify
Support the show
538 Listeners
251 Listeners
808 Listeners
3,336 Listeners
257 Listeners
1,209 Listeners
549 Listeners
1,095 Listeners
694 Listeners
135 Listeners
519 Listeners
349 Listeners
248 Listeners
249 Listeners
1,065 Listeners